Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dalpiciclib (1 trial)
fluzoparib (2 trials)
hetrombopag olamine (1 trial)
hrs4800 (1 trial)
hrs-7085 (1 trial)
hs-10241 (1 trial)
hti-1090 (1 trial)
Rezvilutamide (1 trial)
shr0410 (2 trials)
shr-1314 (1 trial)
shr-1316 (2 trials)
shr-1701 (1 trial)
shr-1703 (1 trial)
shr-1707 (2 trials)
shr-1819 (1 trial)
shr-1905 (1 trial)
shr-2002 (1 trial)
shr2285 (1 trial)
shr4640 (2 trials)
shr-a1811 (1 trial)
shr-a1912 (1 trial)
Acute Pain (Phase 1)
Hyperuricemia (Phase 1)
Neoplasms (Phase 1)
Prostatic Neoplasms (Phase 1)
Pruritus (Phase 1)
Psoriasis (Phase 1)
Trials (25 total)
Trial APIs (21 total)